The HCPLive migraine page is a comprehensive resource for clinical news and insights on migraine headaches. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for migraines, and more.
October 23rd 2024
A new study found that individuals with healthier cardiovascular systems are more likely to develop migraines, linking incident migraine to lower cardiovascular risk.
Expert Medical Witnesses: Should You Get Involved? We Plead the Fifth
September 16th 2008Many physicians are skeptical about getting involved in the practice, and rightfully so. Sermo and other online physician communities are rife with posts and comments from physicians who know colleagues who have stretched the truth or even lied on the stand because of personal beliefs or compensation.
Social Media Notebook: Get on Board the Health Internet Train
September 16th 2008According to an article published in the June 17, 2008 edition of the New York Times, declining reimbursements, managed care, physician shortages (especially in primary care), and concerns about malpractice are contributing to doctors' discontent.
Tech Talk: The Contract You Never Read
September 16th 2008One of the most important legal documents in your practice may have a significant impact on your finances. And even though you (or someone in your practice) agreed to abide by its terms and conditions, it's highly likely that you have never even read it.
The Initiative for Decreasing Disparities in Depression
September 9th 2008What is the most effective way to translate research findings, such as those summarized in the Institute of Medicine report Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care and other published studies, into practice- and behavior altering information and interventions?
Cultural Competency Training in the Garden State: A Q&A with Debbie Salas-Lopez, MD
September 9th 2008In 2005, the New Jersey Legislature passed a law requiring the New Jersey Board of Medical Examiners (NJBME), "in consultation with the Commission on Higher Education, to prescribe requirements, by regulation, for physician training in cultural competency."
Drug Update: Erbitux (cetuximab)
September 4th 2008The US Food and Drug Administration (FDA) is considering a supplemental biologics license application from ImClone Systems Inc requesting that approved uses of Erbitux be expanded to include first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) in combination with platinum-based chemotherapy.